Allergic bronchopulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case series and literature review
ABPA should be considered in COPD patients with persistent or recurrent respiratory symptoms, higher blood eosinophils, particularly those with bronchiectasis on chest CT. ABPA represents a treatable trait in COPD patients. While corticosteroids remain the first-line therapy, treatment-resistant cases may benefit from biologic agents.
Authors
- Yongchang Sun (ORCID: https://orcid.org/0000-0003-3281-8854)
- Lina Sun (ORCID: https://orcid.org/0000-0003-2017-1416)
- Jiaqi Ren (ORCID: https://orcid.org/0000-0003-4759-8102)
- Ying Luo (ORCID: https://orcid.org/0000-0002-9974-6368)
- Chun Chang (ORCID: https://orcid.org/0000-0003-3600-062X)
Institutions
- Peking University (CN)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1186/s12890-025-04027-8
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00